G

Gossamer Bio
D

GOSS

0.15500
USD
-0.00
(-1.59%)
قبل الجلسة·0.16920USD+0.01420(+9.16%)
حجم التداول
3,037,892
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
75,771,242
المقالات
المزيد

العنوان: Gossamer Bio

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).